Commure Raises $70 Million at $7 Billion Valuation to Scale AI-Driven Healthcare Administration

New updates have been reported about Commure.

Commure, an AI-focused healthcare technology company, has secured $70 million in new financing at a post-money valuation of $7 billion, underscoring investor confidence in its ability to automate administrative functions across the healthcare system. The round, led by General Catalyst with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis, positions Commure to expand deployment of its AI agents and infrastructure across health systems and physician practices in the U.S. and abroad.

Commure’s platform, including subsidiary Athelas, is already embedded in more than 500 healthcare organizations and over 3,000 sites of care, integrating with more than 60 electronic health record systems and processing tens of billions of dollars in annual claims. Its end-to-end revenue cycle management tools complete over 85% of workflows without human intervention, while its Ambient AI suite, featuring autonomous coding and clinical intelligence, supports tens of millions of patient appointments annually and is used by more than 130 large health systems as well as thousands of physician-owned practices.

The company’s core focus is tackling administrative costs, one of the largest expense categories in healthcare, with U.S. administrative work alone estimated at roughly $1 trillion annually. By deploying AI agents to handle tasks such as billing, coding, claims processing, denials, and appeals, Commure aims to reduce operating costs for providers, improve margins, and return time to clinicians for direct patient care.

CEO Tanay Tandon emphasized that prior generations of healthcare software digitized paperwork but did not actually execute the underlying work, whereas Commure’s AI agents are now performing these functions at scale in settings ranging from specialty clinics to major health systems. The fresh capital will be used to meet rising demand for these capabilities, deepen AI integration across the front, middle, and back of the revenue cycle, and broaden the company’s footprint within existing customers and new markets.

General Catalyst CEO Hemant Taneja described Commure as a “system of agents” designed for the next era of healthcare, arguing that AI-native infrastructure can fundamentally reshape administrative and clinical workflows and materially impact the cost of care. For executives at provider organizations, Commure’s trajectory suggests a maturing AI market where large-scale, integrated platforms—not point solutions—will likely play a central role in reducing administrative burden, enhancing patient engagement, and enabling more efficient, data-driven operations.